ELI LILLY & Co Total Operating Expenses 2012-2019 | LLY
Beta
No annual data available.
Total Operating Expenses History
| Period | Value | Source | |
|---|---|---|---|
| Q4 FY2019 | $3.28B | +17.4% | 10-K |
| Q3 FY2019 | $2.79B | -6.5% | 10-Q |
| Q2 FY2019 | $2.99B | +8.8% | 10-Q |
| Q1 FY2019 | $2.75B | -11.0% | 10-Q |
| Q4 FY2018 | $3.09B | +12.7% | 10-K |
| Q3 FY2018 | $2.74B | -0.7% | 10-Q |
| Q2 FY2018 | $2.76B | +12.7% | 10-Q |
| Q1 FY2018 | $2.45B | -25.7% | 10-Q |
| Q4 FY2017 | $3.29B | +12.7% | 10-K |
| Q3 FY2017 | $2.92B | -2.8% | 10-Q |
| Q2 FY2017 | $3.00B | +6.2% | 10-Q |
| Q1 FY2017 | $2.83B | -12.8% | 10-Q |
| Q4 FY2016 | $3.24B | +15.7% | 10-K |
| Q3 FY2016 | $2.80B | -5.3% | 10-Q |
| Q2 FY2016 | $2.96B | +9.8% | 10-Q |
| Q1 FY2016 | $2.69B | -16.9% | 10-Q |
| Q4 FY2015 | $3.24B | +19.3% | 10-K |
| Q3 FY2015 | $2.72B | -3.1% | 10-Q |
| Q2 FY2015 | $2.80B | +9.4% | 10-Q |
| Q1 FY2015 | $2.56B | -14.2% | 10-Q |
| Q4 FY2014 | $2.99B | +2.4% | 10-K |
| Q3 FY2014 | $2.92B | +2.0% | 10-Q |
| Q2 FY2014 | $2.86B | +10.2% | 10-Q |
| Q1 FY2014 | $2.59B | -24.3% | 10-Q |
| Q4 FY2013 | $3.43B | +13.2% | 10-K |
| Q3 FY2013 | $3.03B | -5.3% | 10-Q |
| Q2 FY2013 | $3.20B | +6.6% | 10-Q |
| Q1 FY2013 | $3.00B | -12.8% | 10-Q |
| Q4 FY2012 | $3.44B | +11.0% | 10-K |
| Q3 FY2012 | $3.10B | -4.7% | 10-Q |
| Q2 FY2012 | $3.25B | +8.4% | 10-Q |
| Q1 FY2012 | $3.00B | - | 10-Q |
Company: ELI LILLY & CoTicker: LLYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →